Isotretinoin Drugs Market Size, Share, Growth & Industry Forecast to 2027

Global Isotretinoin Drugs Market Size, Share, Growth, Industry Trends, Competitive Analysis and Forecast to 2030

Report ID: RC145013 | Report Format: PDF + Excel | Starting Price: 2520/- USD | Last Updated: April 9th, 2023

The global isotretinoin drugs market size is accounted to grow at a significant CAGR of over 3.2% during the forecast period 2021 to 2027 and expected to reach over USD 1,700 million by 2027. The increasing incidence of skin complications around the world is a primary factor to drive market growth. Furthermore, the rising skin disorder and growing skin cancer cases are some other factors to propel the market. According to the latest research, 108,420 new skin cancer cases found in the United States in 2020, and 11,480 deaths were accounted for in the United States in 2020 due to skin cancer. Moreover, effective implementation of treatment guidelines related to skin diseases is projected to uplift the market over the forecast period.

Report Attributes:

Benchmark Year		2022
Market Size
Market Growth (CAGR)		> 3.2%
Largest Market Share
Analysis Period		2020-2030
Market Players		Teva Pharmaceutical Industries Limited, F.Hoffmann-La Roche Ltd., Mylan Pharmaceutical Industries Ltd, GlaxoSmithKline, Plc., and Almirall, S.A.

Market Insights:

The global isotretinoin drugs market is bifurcated into clinical application, distribution channel, and geography. On the basis of clinical application, the market is further classified into dermatology, cancer, and other applications. The dermatology segment is accounted to hold the largest market share in terms of revenue. The increasing incidence of acne in the young population is a primary factor to drive the segment growth across the globe. As per the latest stats shared by NIH (National Institute of Health), 90% of the young population is facing acne problems around the world.

By distribution channel, the isotretinoin drugs market is segmented into hospital pharmacy, retail pharmacy, and others. The hospital pharmacy segment held the largest market share and expected to grow at the same trend over the forecast period. By region, North America dominated the market in 2020 globally due to the increasing incidence of dermatology complications across the globe. According to the latest information shared by the American Academy of Dermatology (AAD), around 40 million people suffer from acne in the United States.

Isotretinoin Drugs Market Size and Growth

To know more about the study, request a report sample

The isotretinoin drugs comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2020 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The isotretinoin drugs market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

2018-19 – Historical Year
2020 – Base Year
2021-2027 – Forecast Period

Market Segmentation:

By Clinical Application:

Dermatology
Cancer
Others

By Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Others

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Geographic Coverage:

Geographically, the isotretinoin drugs market report comprises dedicated sections centering on the regional market revenue and trends. The isotretinoin drugs market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. The isotretinoin drugs market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Isotretinoin drugs market estimates have also been provided for the historical years 2018 & 2019 along with forecasts for the period from 2021 – 2027.

Competition Assessment:

Key players operating in the global isotretinoin drugs market are Teva Pharmaceutical Industries Limited, F.Hoffmann-La Roche Ltd., Mylan Pharmaceutical Industries Ltd, GlaxoSmithKline, Plc., and Almirall, S.A. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

Teva Pharmaceutical Industries Limited
Hoffmann-La Roche Ltd.
Mylan Pharmaceutical Industries Ltd
GlaxoSmithKline, Plc.
Almirall, S.A.
Amneal Pharmaceutical, Inc.
Sun Pharmaceutical Industries Ltd.
Reddys Laboratories Ltd.
Pierre Fabre
Orion Pharman

Key Questions Answered by Isotretinoin Drugs Market Report:

Global isotretinoin drugs market forecasts from 2021-2027
Regional isotretinoin drugs market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
Isotretinoin drugs submarket forecasts from 2021-2027 covering the market by type, by function, by end-use, and geography
Various industry models such as SWOT analysis, Value Chain Analysis pertaining to isotretinoin drugs market
Analysis of the key factors driving and restraining the growth of the global, regional and country-level isotretinoin drugs markets from 2021-2027
Competitive Landscape and market positioning of top 10 players operating in the isotretinoin drugs market

Table of Content:

1. Preface

1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

2. Executive Summary

2.1. Global Isotretinoin Drugs Market Portraiture
2.2. Global Isotretinoin Drugs Market, by Clinical Application, 2020 (USD Mn)
2.3. Global Isotretinoin Drugs Market, by Distribution Channel, 2020 (USD Mn)
2.4. Global Isotretinoin Drugs Market, by Geography, 2020 (USD Mn)

3. Global Isotretinoin Drugs Market Analysis

3.1. Isotretinoin Drugs Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery

4. Global Isotretinoin Drugs Market By Clinical Application, 2018 – 2027 (USD Mn)

4.1. Overview
4.2. Dermatology
4.3. Cancer
4.4. Others

5. Global Isotretinoin Drugs Market By Distribution Channel, 2018 – 2027 (USD Mn)

5.1. Overview
5.2. Hospital Pharmacy
5.3. Retail Pharmacy
5.4. Others

6. North America Isotretinoin Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)

6.1.1. Overview
6.1.2. North America Isotretinoin Drugs Market by Clinical Application (2018-2027 USD Mn)
6.1.3. North America Isotretinoin Drugs Market by Distribution Channel (2018-2027 USD Mn)
6.1.4. North America Isotretinoin Drugs Market by Country (2018-2027 USD Mn)
6.1.4.1. U.S.
6.1.4.2. Canada

7. Europe Isotretinoin Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)

7.1.1. Overview
7.1.2. Europe Isotretinoin Drugs Market by Clinical Application (2018-2027 USD Mn)
7.1.3. Europe Isotretinoin Drugs Market by Distribution Channel (2018-2027 USD Mn)
7.1.4. Europe Isotretinoin Drugs Market by Country (2018-2027 USD Mn)
7.1.4.1. Germany
7.1.4.2. U.K.
7.1.4.3. France
7.1.4.4. Italy
7.1.4.5. Rest of Europe

8. Asia Pacific Isotretinoin Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)

8.1.1. Overview
8.1.2. Asia Pacific Isotretinoin Drugs Market by Clinical Application (2018-2027 USD Mn)
8.1.3. Asia Pacific Isotretinoin Drugs Market by Distribution Channel (2018-2027 USD Mn)
8.1.4. Asia Pacific Isotretinoin Drugs Market by Country (2018-2027 USD Mn)
8.1.4.1. China.
8.1.4.2. Japan
8.1.4.3. Rest of Asia Pacific

9. Latin America (LATAM) Isotretinoin Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)

9.1.1. Overview
9.1.2. Latin America Isotretinoin Drugs Market by Clinical Application (2018-2027 USD Mn)
9.1.3. Latin America Isotretinoin Drugs Market by Distribution Channel (2018-2027 USD Mn)
9.1.4. Latin America Isotretinoin Drugs Market by Country (2018-2027 USD Mn)
9.1.4.1. Brazil
9.1.4.2. Mexico
9.1.4.3. Rest of Latin America

10. Middle East and Africa Isotretinoin Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)

10.1.1. Overview
10.1.2. MEA Isotretinoin Drugs Market by Clinical Application (2018-2027 USD Mn)
10.1.3. MEA Isotretinoin Drugs Market by Distribution Channel (2018-2027 USD Mn)
10.1.4. Middle East and Africa Isotretinoin Drugs Market, by Country (2018-2027 USD Mn)
10.1.4.1. GCC
10.1.4.2. Rest of MEA

11. Company Profiles

11.1. Teva Pharmaceutical Industries Limited
11.1.1. Business Description
11.1.2. Financial Health and Budget Allocation
11.1.3. Product Positions/Portfolio
11.1.4. Recent Development
11.1.5. SWOT Analysis
11.2. F.Hoffmann-La Roche Ltd.
11.2.1. Business Description
11.2.2. Financial Health and Budget Allocation
11.2.3. Product Positions/Portfolio
11.2.4. Recent Development
11.2.5. SWOT Analysis
11.3. Mylan Pharmaceutical Industries Ltd
11.3.1. Business Description
11.3.2. Financial Health and Budget Allocation
11.3.3. Product Positions/Portfolio
11.3.4. Recent Development
11.3.5. SWOT Analysis
11.4. GlaxoSmithKline, Plc.
11.4.1. Business Description
11.4.2. Financial Health and Budget Allocation
11.4.3. Product Positions/Portfolio
11.4.4. Recent Development
11.4.5. SWOT Analysis
11.5. Almirall, S.A.
11.5.1. Business Description
11.5.2. Financial Health and Budget Allocation
11.5.3. Product Positions/Portfolio
11.5.4. Recent Development
11.5.5. SWOT Analysis
11.6. Amneal Pharmaceutical, Inc.
11.6.1. Business Description
11.6.2. Financial Health and Budget Allocation
11.6.3. Product Positions/Portfolio
11.6.4. Recent Development
11.6.5. SWOT Analysis
11.7. Sun Pharmaceutical Industries Ltd.
11.7.1. Business Description
11.7.2. Financial Health and Budget Allocation
11.7.3. Product Positions/Portfolio
11.7.4. Recent Development
11.7.5. SWOT Analysis
11.8. Dr. Reddys Laboratories Ltd.
11.8.1. Business Description
11.8.2. Financial Health and Budget Allocation
11.8.3. Product Positions/Portfolio
11.8.4. Recent Development
11.8.5. SWOT Analysis
11.9. Pierre Fabre
11.9.1. Business Description
11.9.2. Financial Health and Budget Allocation
11.9.3. Product Positions/Portfolio
11.9.4. Recent Development
11.9.5. SWOT Analysis
11.10. Orion Pharman
11.10.1. Business Description
11.10.2. Financial Health and Budget Allocation
11.10.3. Product Positions/Portfolio
11.10.4. Recent Development
11.10.5. SWOT Analysis

To know more about the study, request a report sample

List of Tables:

TABLE 1 Market Snapshot: Global Isotretinoin Drugs Market

TABLE 2 Impact Indicators

TABLE 3 Impact Analysis of Drivers and Challenges

TABLE 4 Global Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 5 Global Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 6 North America Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 7 North America Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 8 North America Isotretinoin Drugs Market Value, By Country, 2018 - 2027 (US$ Mn)

TABLE 9 U.S. Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 10 U.S. Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 11 Canada Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 12 Canada Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 13 Europe Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 14 Europe Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 15 Europe Isotretinoin Drugs Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 16 Germany Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 17 Germany Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 18 U.K. Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 19 U.K. Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 20 France Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 21 France Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 22 Italy Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 23 Italy Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 24 Rest of Europe Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 25 Rest of Europe Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 26 Asia Pacific Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 27 Asia Pacific Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 28 Asia Pacific Isotretinoin Drugs Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 29 Japan Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 30 Japan Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 31 China Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 32 China Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 33 Rest of Asia Pacific Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 34 Rest of Asia Pacific Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 35 Latin America Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 36 Latin America Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 37 Latin America Isotretinoin Drugs Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 38 Brazil Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 39 Brazil Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 40 Mexico Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 41 Mexico Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 42 Rest of Latin America Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 43 Rest of Latin America Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 44 Middle East & Africa Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 45 Middle East & Africa Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 46 Middle East & Africa Isotretinoin Drugs Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 47 GCC Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 48 GCC Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 49 Rest of MEA Isotretinoin Drugs Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 50 Rest of MEA Isotretinoin Drugs Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 51 Teva Pharmaceutical Industries Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 52 F.Hoffmann-La Roche Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 53 Mylan Pharmaceutical Industries Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 54 GlaxoSmithKline, Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 55 Almirall, S.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 56 Amneal Pharmaceutical, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 57 Sun Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 58 Dr. Reddys Laboratories Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 59 Pierre Fabre: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 60 Orion Pharman: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

To know more about the study, request a report sample

List of Figures:

FIG. 1 Global Isotretinoin Drugs: Market Segmentation

FIG. 2 Global Isotretinoin Drugs Market: Research Methodology

FIG. 3 Top-Down and Bottom-up Approach

FIG. 4 Global Isotretinoin Drugs Market, by Clinical Application, 2019 (US$ Mn)

FIG. 5 Global Isotretinoin Drugs Market, by Distribution Channel, 2019 (US$ Mn)

FIG. 6 Global Isotretinoin Drugs Market, by Geography, 2019 (US$ Mn)

FIG. 7 Global Isotretinoin Drugs Market Value and Growth, 2018 – 2027, (US$ Mn) (Y-o-Y %)

FIG. 8 Attractive Investment Proposition, by Geography, 2017

FIG. 9 Market Positioning of Key Isotretinoin Drugs Providers, 2019

FIG. 10 Global Isotretinoin Drugs Market Value Share, by Clinical Application, 2018 & 2027 (%)

FIG. 11 Global Isotretinoin Drugs Market Value for Dermatology, 2018 - 2027, (US$ Mn)

FIG. 12 Global Isotretinoin Drugs Market Value for Cancer, 2018 - 2027, (US$ Mn)

FIG. 13 Global Isotretinoin Drugs Market Value for Others, 2018 - 2027, (US$ Mn)

FIG. 14 Global Isotretinoin Drugs Market Value Share, by Distribution Channel, 2018 & 2027 (Value %)

FIG. 15 Global Isotretinoin Drugs Market Value for Hospital Pharmacy, 2018 - 2027, (US$ Mn)

FIG. 16 Global Isotretinoin Drugs Market Value for Retail Pharmacy, 2018 - 2027, (US$ Mn)

FIG. 17 Global Isotretinoin Drugs Market Value for Others, 2018 - 2027, (US$ Mn)

FIG. 18 North America Isotretinoin Drugs Market Value, 2018 - 2027, (US$ Mn)

FIG. 19 Europe Isotretinoin Drugs Market Value, 2018 - 2027, (US$ Mn)

FIG. 20 Asia Pacific Isotretinoin Drugs Market Value, 2018 - 2027, (US$ Mn)

FIG. 21 LATIN America Isotretinoin Drugs Market Value, 2018 - 2027, (US$ Mn)

FIG. 22 Middle East & Africa Isotretinoin Drugs Market Value, 2018 - 2027, (US$ Mn)

Fill the given form to inquiry before buying for Isotretinoin Drugs Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample

Inquiry Before Buying

Schedule a Call

Select License Type

$ 3600/- Single User License
$2520 (Limited Time Offer)
$ 5200/- Multi User License
$ 6995/- Corporate License

For Any Assitance

Email: sales@researchcorridor.com